Stockscreener 앱 받기
0.9385
1.22%
0.0113
시간 외 거래:
.97
0.0315
+3.36%
Biocardia Inc 주식(BCDA)의 최신 뉴스
BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific Meeting - GlobeNewswire Inc.
BioCardia president and CEO Peter Altman buys $1,030 in shares - Investing.com
At $1.03 a share, BioCardia (BCDA) CEO Peter Altman buys 1,000 shares. - Stock Titan
BioCardia CEO Peter Altman buys $1,995 in stock By Investing.com - Investing.com Canada
BioCardia CEO Peter Altman buys $1,995 in stock - Investing.com
BioCardia (BCDA) CEO buys shares at an average $1.05 each, bringing his direct holdings to 383,885. - Stock Titan
BioCardia Shares Fall 10% After Hours: Here's Why - Benzinga
BioCardia Shares Fall 10% After Hours: Here's Why - TradingView
Form 8K Biocardia Inc For: 10 September By Investing.com - Investing.com Canada
Form 8K Biocardia Inc For: 10 September By Investing.com - Investing.com India
Form 8K Biocardia Inc For: 10 September By Investing.com - Investing.com UK
BioCardia to Present CardiAMP, Helix and Heart3D Progress at H.C. Wainwright Global Investment Conference - Quiver Quantitative
BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times
BioCardia to present CardiAMP regulatory progress, Helix and Heart3D updates at H.C. Wainwright - TradingView
A heart-failure cell therapy could reach Japanese regulators by year-end. BioCardia is preparing the filing. - Stock Titan
Form 8K Biocardia Inc For: 10 September By Investing.com - Investing.com Nigeria
BioCardia CEO Peter Altman buys 800 shares for $872 - Bitget
BioCardia CEO Peter Altman buys $872 in company stock By Investing.com - Investing.com Nigeria
BioCardia CEO Peter Altman buys $872 in company stock - Investing.com
BioCardia CEO Peter Altman buys $872 in company stock By Investing.com - Investing.com South Africa
BioCardia CEO Peter Altman buys $872 in company stock - Investing.com
BioCardia (BCDA) CEO adds 800 shares in open-market buy - Stock Titan
BioCardia Inc. Warrant (BCDAW) Key Financial Ratios – Valuation, Profitability & More - Value Research
BioCardia (BCDA) Session: Finishes 4.95% Higher at $1.06 at the Close; Price Setup: Price Remains Between $1.01 Support and $1.11 Resistance on the DaySmart Beta Flow - vinanet.vn
BioCardia receives FDA confirmation on Helix catheter meeting By Investing.com - Investing.com Nigeria
BioCardia Advances Helix Catheter Toward De Novo Approval - TipRanks
BioCardia receives FDA confirmation on Helix catheter meeting By Investing.com - Investing.com India
BioCardia (BCDA) Session: Finishes 4.95% Higher at $1.06 at the Close; Price Setup: Price Remains Between $1.01 Support and $1.11 Resistance on the DayDonchian Channel - dars.gov.et
BioCardia Receives Nasdaq Notice on Minimum Bid Price - The Globe and Mail
BioCardia Received Notice of Noncompliance - TradingView
BioCardia’s Q2 2026 Update Keeps the Regulatory Story Alive, but Capital Still Drives the Risk - AlphaStreet
BioCardia CEO Peter Altman acquires 5,400 common shares worth $5,022 - Bitget
BioCardia CEO Peter Altman buys $5,022 in company stock - Investing.com
BioCardia CEO Peter Altman buys $5,022 in company stock - Investing.com
BioCardia (BCDA) CEO buys 5,400 shares in open market - Stock Titan
BCDA Q2 2026 Earnings: EPS Surprise of 29.19% Narrows Losses as Shares Climb 4.82%Estimate Revision Count - vinanet.vn
BioCardia (BCDA) Pushes Higher: Micro-Cap Biotech Gains 4.8% as It Nears $1.02 ResistanceIceberg Order - vinanet.vn
BioCardia (BCDA) Pushes Higher: Micro-Cap Biotech Gains 4.8% as It Nears $1.02 ResistanceValue Area High - dars.gov.et
BCDA Q2 2026 Earnings: Narrower-than-Expected Loss Drives Shares Up 4.82%Earnings Revision Upgrade - vinanet.vn
Why Did BCDA Stock Surge More Than 50% Today? - Stocktwits
BioCardia CEO Peter Altman buys $1,748 in company stock By Investing.com - Investing.com Canada
BioCardia CEO Peter Altman buys $1,748 in company stock - Investing.com
BioCardia CEO Peter Altman buys $1,748 in company stock By Investing.com - Investing.com India
BioCardia CEO Peter Altman buys $1,748 in company stock By Investing.com - Investing.com UK
BioCardia (BCDA) CEO Peter Altman purchases 1,900 shares at $0.92 average price - Stock Titan
BioCardia (BCDA) Holds at $0.88 as Range-Bound Trading PersistsTriple Top - vinanet.vn
BioCardia (BCDA) Drops 5.6% to $0.88 as Micro-Cap Biotech Tests Support LevelInsider Buying Alerts - vinanet.vn
BioCardia (BCDA) Advances Regulatory Pathway, Faces High Price-t - GuruFocus
BioCardia Inc (BCDA) (Q2 2026) Earnings Call Highlights: Regulatory Wins in Japan and US ... - Yahoo! Finance Canada
BioCardia Inc (BCDA) (Q2 2026) Earnings Call Highlights: Regulat - GuruFocus
1.35%
자본화:
|
볼륨(24시간):